Chloe L Thio

Medicine & Life Sciences

1. Hepatitis B virus 100%
2. HIV 98%
3. Hepacivirus 77%
4. Hepatitis B 55%
5. Virus Diseases 40%
6. Coinfection 32%
7. Chronic Hepatitis B 28%
8. Highly Active Antiretroviral Therapy 22%
9. Lamivudine 22%
10. Hepatitis C 21%
11. Tenofovir 19%
12. HIV-1 18%
13. Single Nucleotide Polymorphism 18%
14. Odds Ratio 15%
15. Vertical Infectious Disease Transmission 15%
16. Liver Diseases 14%
17. HIV Infections 14%
18. Cohort Studies 14%
19. Antiviral Agents 13%
20. Confidence Intervals 13%
21. Therapeutics 13%
22. Haplotypes 13%
23. HLA Antigens 13%
24. Sexual and Gender Minorities 12%
25. Acquired Immunodeficiency Syndrome 12%
26. Genes 11%
27. DNA 11%
28. Genotype 11%
29. Hepatitis B Surface Antigens 10%
30. Interferons 10%
31. Genome-Wide Association Study 10%
32. Alleles 10%
33. African Americans 10%
34. Liver 9%
35. Hepatitis Viruses 9%
36. Liver Cirrhosis 9%
37. CD4 Lymphocyte Count 9%
38. Infections 9%
39. Hepatitis 9%
40. entecavir 8%
41. Hepatitis C Antibodies 8%
42. Hepatitis B e Antigens 8%
43. Nigeria 8%
44. RNA 7%
45. Mortality 7%
46. Communicable Diseases 7%
47. Genomics 7%
48. Viruses 7%
49. KIR Receptors 7%
50. Fibrosis 6%